Moderna's Melanoma Result Landed On A Market Positioned The Other Way
Yahoo Finance · Aug 20, 2026 · Sarepta Therapeutics Inc (SRPT)
The trial met both endpoints in the readout, removing the inconclusive outcome management itself had flagged, and short sellers in the stock took a record single-session loss.
Not investment advice. Cached headline, not a full reprint.